SYNOPSIS Most of the antibody activity of plasma was found to remain in the supernatant fraction following the preparation of factor-VIII-rich cryoprecipitates. The low level of antibody remaining in these cryoprecipitates indicated that they could safely be used as a source of factor VIII for replacement therapy. Washing the cryoprecipitates farther reduced their antibody titres without materially affecting their factor VIII content.
Following recent reports of success in preventing Rhesus isoimmunization in the early puerperium, by the injection of a high titre anti-D antibody (Woodrow, Clarke, Donohoe, Finn, McConnell, Sheppard, Lehane, Russell, Kulbe, and Durkin, 1965) it appears likely that this will become a standard procedure. Large amounts of high titre anti-D (anti-Rh) gamma globulin will be required and these will have to be obtained from deliberately immunized male volunteers.
This study was undertaken to determine whether plasma obtained from Rh-sensitized individuals could be used to prepare an antihaemophilic globulin-rich cryoprecipitate without detracting from its usefullness as a source of anti-D.
MATERIALS AND METHODS
Two 20 ml aliquots of blood were taken from Rhsensitized women using disposable plastic syringes. These were each added to 5 ml acid citrate dextrose (ACD) in glass Universal containers and immediately centrifuged for 15 minutes at 3,000 r.p.m. at 4°C in an MSE Mistral centrifuge. The plasma was pooled and two 10 ml aliquots were placed in Universal containers labelled 'cryoprecipitate' and 'cryoprecipitate (washed)', the remainder being labelled 'whole plasma'. The three samples were frozen at -20°C for several hours after which the first two aliquots were transferred to a refrigerator and allowed to thaw out overnight at 4°C. These samples were centrifuged at 4°C for 15 min at 3,000 r.p.m. and the supematant plasma was decanted, pooled, and refrozen. One ml citrate-saline at 4°C (1 part 3-8% trisodium citrate and 9 parts 0-9% NaCl) was added to the 'cryoReceived for publication 11 January 1968. precipitate' specimen which was immediately refrozen at -20°C while 10 ml citrate saline was added to the 'cryoprecipitate (washed)' specimen. This was mixed by gentle inversion without the precipitate being allowed to dissolve and centrifuged at 4°C and 3,000 r.p.m. for 15 minutes. The supematant was discarded, a further 1 ml citrate saline added, and the specimen refrozen. Within a week of preparation, the samples were thawed out at 37°C and factor VIII levels in both the cryoprecipitate specimens measured by a one-stage method (Hardisty and Macpherson, 1962) . A pool of blood from at least five haematologically normal staff was taken as 100% normal. Antibody titres were then measured in all four specimens by the indirect antiglobulin (Coombs) test except where otherwise stated.
RESULTS
There was no reduction in antibody titre in the supernatant plasma after removal of the cryoprecipitate as compared with whole plasma (Table I) .
The cryoprecipitates showed on average a four to eightfold drop in titre from the original plasma, and washing of the cryoprecipitate resulted in a further halving of the antibody level. These results were not corrected for volume changes, and as the cryoprecipitate had been reduced to one tenth of the volume of the original plasma it would appear that only about 1 % of the antibody remained in the washed cryoprecipitate.
Factor VIII levels in the cryoprecipitate averaged 920 % of normal, ie, equivalent to 92 % in the volume of the original plasma. Washing the cryoprecipitate had little effect on the factor VIII level except in one instance (case 8). 
